Investor FAQ

Investor FAQ


Where is XBiotech's corporate headquarters?
XBiotech’s corporate headquarters are located at 5217 Winnebago Ln, Austin, TX, 78744
Where is the company incorporated?
XBiotech Inc. was incorporated in Canada on March 22, 2005. XBiotech has four wholly-owned subsidiaries: XBiotech USA, Inc., incorporated in Delaware; XBiotech Switzerland AG, incorporated in Zug, Switzerland; XBiotech Japan K.K., incorporated in Tokyo, Japan; and XBiotech Germany GmbH, incorporated in Germany.
When did XBiotech go public?
XBiotech began trading on the NASDAQ stock market on April 15, 2015.
What is XBiotech’s fiscal year?
XBiotech’s fiscal year is from January 1 to December 31.
How is XBiotech’s stock traded?
XBiotech’s stock is traded as common stock on the NASDAQ stock market under the ticker symbol “XBIT”.


Who is XBiotech's transfer agent?
The transfer agent and registrar for shares of XBiotech’s common stock is Equiniti Trust Company, LLC.
Whom do I contact with questions about my stock?
Contact XBiotech’s transfer agent, Equiniti Trust Company, LLC:

Equiniti Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Phone: (800) 937-5449
Corporate Website:

How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?
Equiniti Trust Company, LLC is available to assist shareholders with stock transfers, changes of address, and replacement of lost stock certificates.

Equiniti Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Phone: (800) 937-5449
Corporate Website:

Does XBiotech have a direct stock purchase plan?
No, XBiotech does not have a direct stock purchase plan.


Who is XBiotech's auditor?
XBiotech’s auditor is Ernst & Young, LLP.
Who is XBiotech's legal counsel?
XBiotech’s legal counsel in matters relating to Canadian law is Stikeman Elliott, LLP. In matters relating to American law, XBiotech’s legal counsel is Bryan Cave LLP.


Where can I get the latest corporate news releases and financial reports?
All latest corporate news releases and financial reports can be found under “Investors” on XBiotech’s website under “Press Releases
How can I view documents XBiotech has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
SEC filings can be found in the “Investors” section XBiotech’s website under “SEC Filings"
Who makes up the XBiotech Executive Management team and Board of Directors?
XBiotech’s Executive Management team consists of John Simard, Founder, President, Chief Executive Officer & Chairman; Sushma Shivaswamy, Ph.D., Chief Scientific Officer; Norma I. Gonzalez , Vice President of Quality; Qian Wu Ph.D., Vice President of Quality Control; Queena Han, C.P.A, C.G.A., Vice President of Finance and Human Resources; Ashley Otero, Vice President of Clinical Operations.

The Board of Directors is comprised of John Simard, Chairman, W. Thorpe McKenzie, Jan-Paul Waldin, Donald H. MacAdam, and Peter Libby, MD.

More information on XBiotech’s Executive Management team and Board of Directors can be found on our website: in the “Investors” section under "Corporate Governance".
How can I obtain further information or materials on XBiotech?
To get more information or materials on XBiotech, please visit the “Contact Us” section of the website to fill out the form to request information via email.

You can also contact XBiotech at:
Phone: (512) 386-2900
Fax: (512) 386-5505
How can I receive email updates for upcoming press releases?
You can sign up for email updates through XBiotech’s distribution list in the “Investors” section of our website.

xbiotech logo